views
The study on the Global veterinary vaccines Market is the latest report covering the impact analysis of the currently ongoing COVID-19 pandemic. The pandemic has directly affected the market by causing disruptions in the global veterinary vaccines by inducing financial difficulties. The veterinary vaccines market has witnessed dynamic changes in trends and demands owing to the ongoing COVID-19 pandemic. The report provides a detailed outlook on how the pandemic has affected the key segments of the veterinary vaccines industry. The report includes an in-depth impact analysis of the COVID-19 pandemic on the overall veterinary vaccines industry.
The Global veterinary vaccines Market report presents comprehensive information covering insightful data for businesses and investors for the time period of 2020-2027. The report studies the historical data of the veterinary vaccines market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects. The report offers an accurate forecast estimation of the veterinary vaccines industry based on the recent technological and research advancements. It also offers valuable data to assist the investors in formulating strategic business investment plans and capitalize on the emerging growth prospects in the veterinary vaccines market.
Get a sample of the report : https://www.emergenresearch.com/request-sample/426
Key Highlights of Report
In January 2020, Automazioni VX, Inc. entered into a cooperative agreement with Merck Animal Health, a division of Merck KGaA. The collaboration was aimed to launch Innoject Pro, a uniquely developed technology for subcutaneous injection vaccination of chicken. The technology can be utilized in conjunction with the Innovax vaccine by Merck Animal Health, which is used to safeguard poultry from bacterial infections.
The poultry segment is expected to lead the global veterinary vaccines market throughout the forecast period, expanding at a CAGR of 7.0%. The increased need for risk-free pet food, associated with a growing focus on developing new animal protection approaches, is estimated to drive the segment during the forecast period.
The injection segment is projected to retain the largest market share throughout the forecast period. Growth of the segment is attributable to increasing use of injection vaccines for protection of animal health. Injection vaccines play a crucial role in preventing and controlling the dissemination of disease outbreaks in both farm animals and livestock.
Throughout the forecast period, the inactivated segment is expected to dominate the market for veterinary vaccines. Inactivated vaccines are free from bacteria and suitable for rehabilitation, except in case of immunocompetent patients. These vaccines are usually compressed, which makes their shipping and preserving simple.
Due to growing prevalence of viral infections among livestock, including the Nipah virus infection, avian influenza, canine influenza, swine flu, and bird flu, the viral segment is expected to lead the market during the forecast period.
North America is expected to dominate the global market for veterinary vaccines during the forecast period, due to rising incidence of animal diseases and growing population of pets in the U.S.
Key market participants include Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.
The veterinary/animal vaccines market is likely to expand rapidly, due to the growing use of vaccines to treat zoonotic disorders and increasing inclination to use fewer antibiotics. Moreover, the rising rate of incidence of livestock disorders is anticipated to propel the veterinary vaccines market further during the forecast period.However, during the forecast period, the global veterinary vaccines market is likely to be hampered by lack of appropriate standards and quality controls in veterinary vaccine production.
Request a discount on the report : https://www.emergenresearch.com/request-discount/426
Emergen Research has segmented the global veterinary vaccines market based on type, administration path, technology, infection, and region.
Type Outlook (Revenue, USD Billion; 2017–2027)
- Poultry
- Swine
- Aquaculture
- Cattle
- Cat
- Dog
Administration Path Outlook (Revenue, USD Billion; 2017–2027)
- Oral
- Injection
- Spray/Immersion
Technology Outlook (Revenue, USD Billion; 2017–2027)
- Inactivated
- Live Attenuated
- Recombinant
- Toxoid
Infection Outlook (Revenue, USD Billion; 2017–2027)
- Fungal
- Bacterial
- Parasitic
- Viral
TOC of the global veterinary vaccines market report:
Chapter 1, describes the veterinary vaccines Introduction, market overview, product offerings, growth opportunities, market risks, driving forces, and challenges.
Chapter 2, analyzes the key manufacturers of veterinary vaccines , along with the sales, revenue, and price of veterinary vaccines , in the forecast period.
Chapter 3, studies the competitive situation among the major manufacturers and vendors, with sales, revenue, and market share.
Chapter 4, analyzes the global market by regions, with sales, revenue, and market share of veterinary vaccines , for each region, from 2020 to 2027.
Chapters 5, 6, 7, 8 and 9, analyze the veterinary vaccines market by type, application, regions, and manufacturers, with sales, revenue, and market share by key countries in these regions…Continued
Read More: https://www.emergenresearch.com/industry-report/veterinary-vaccines-market
Related reports:
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]